X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (30) 30
atrial fibrillation (26) 26
index medicus (24) 24
humans (19) 19
risk factors (18) 18
heart failure (16) 16
peripheral vascular disease (15) 15
aged (14) 14
male (14) 14
stroke (14) 14
female (13) 13
aged, 80 and over (10) 10
japan - epidemiology (9) 9
middle aged (9) 9
mortality (9) 9
registries (9) 9
outcomes (8) 8
time factors (8) 8
care and treatment (7) 7
end-point definitions (7) 7
management (7) 7
prognosis (7) 7
incidence (6) 6
patient outcomes (6) 6
predicting stroke (6) 6
risk (6) 6
stroke - epidemiology (6) 6
treatment outcome (6) 6
warfarin (6) 6
anticoagulants (5) 5
atrial fibrillation - epidemiology (5) 5
cardiac patients (5) 5
cardiology (5) 5
complications and side effects (5) 5
kaplan-meier estimate (5) 5
original research (5) 5
research (5) 5
thromboembolism (5) 5
valve implantation (5) 5
analysis (4) 4
animals (4) 4
aortic stenosis (4) 4
atrial fibrillation - diagnosis (4) 4
atrial fibrillation - drug therapy (4) 4
atrial-fibrillation (4) 4
cause of death (4) 4
disease (4) 4
heart (4) 4
hospitalization (4) 4
ischemia (4) 4
ischemic-stroke (4) 4
prevention (4) 4
prospective studies (4) 4
usage (4) 4
valvular heart disease (4) 4
adults (3) 3
antithrombotic therapy (3) 3
aortic valve replacement (3) 3
atrial fibrillation - complications (3) 3
biomarkers (3) 3
biomedical engineering (3) 3
cardiac surgery (3) 3
cardiovascular (3) 3
cell-death (3) 3
cells, cultured (3) 3
clinical neurology (3) 3
coronary heart disease (3) 3
electrocardiography (3) 3
follow-up studies (3) 3
guidelines (3) 3
health aspects (3) 3
heart diseases (3) 3
hemoglobin (3) 3
iscp 2018 best posters (3) 3
lymphangiogenesis (3) 3
medicine & public health (3) 3
oxidative stress (3) 3
pharmacology & pharmacy (3) 3
predictors (3) 3
proportional hazards models (3) 3
rats (3) 3
rats, wistar (3) 3
replacement (3) 3
retrospective studies (3) 3
sinus rhythm (3) 3
stroke - diagnosis (3) 3
surgery (3) 3
survival (3) 3
vascular surgery (3) 3
administration, oral (2) 2
age factors (2) 2
american-college (2) 2
anemia (2) 2
angiography (2) 2
animals, newborn (2) 2
anticoagulants - administration & dosage (2) 2
anticoagulants - therapeutic use (2) 2
anticoagulation (2) 2
aorta (2) 2
aortic valve (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation Journal, ISSN 1346-9843, 2015
Journal Article
Circulation Journal, ISSN 1346-9843, 2016, Volume 80, Issue 1, pp. 62 - 63
Journal Article
Circulation Journal, ISSN 1346-9843, 2019, Volume 83, Issue 4, pp. 707 - 708
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 06/2018, Volume 137, Issue 2, pp. 105 - 109
Depending on the characteristics of patients, the blood concentration of apixaban can unexpectedly increase, possibly leading to bleeding events. Anti-FXa... 
Drug monitoring | Atrial fibrillation | New oral anticoagulants | Apixaban | DABIGATRAN | RIVAROXABAN | ASSAYS | PHARMACOLOGY & PHARMACY | TIME | ATRIAL-FIBRILLATION | Evaluation | Pharmacology, Experimental | Patient outcomes | Physiological aspects | Blood clotting | Health status indicators | Index Medicus
Journal Article
Heart and Vessels, ISSN 0910-8327, 12/2018, Volume 33, Issue 12, pp. 1534 - 1546
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 04/2014, Volume 126, Issue 3, pp. 274 - 280
We previously reported that serofendic acid, a lipophilic extract of fetal calf serum, protects against oxidative stress in primary culture of neonatal rat... 
mitochondrial ATP-sensitive potassium channel | serofendic acid | myocardial ischemia | reperfusion | cardiac myocyte | Myocardial ischemia | Reperfusion | Cardiac myocyte | Mitochondrial atp-sensitive potassium channel | Serofendic acid | SENSITIVE POTASSIUM CHANNELS | OXIDATIVE STRESS | DEATH PATHWAY | CARDIAC MYOCYTES | FETAL CALF SERUM | POSSIBLE MECHANISM | CELL-DEATH | MITOCHONDRIAL PERMEABILITY TRANSITION | K-ATP CHANNEL | PHARMACOLOGY & PHARMACY | CARDIOPROTECTION | Injections, Intravenous | Mitochondria, Heart - metabolism | Mitochondria, Heart - pathology | Male | Mitochondria, Heart - drug effects | Membrane Potential, Mitochondrial - drug effects | Dose-Response Relationship, Drug | Potassium Channels - metabolism | Myocardial Reperfusion Injury - pathology | Diterpenes - administration & dosage | Time Factors | Protective Agents - pharmacology | Myocardial Infarction - pathology | Myocardial Infarction - physiopathology | Blood Pressure - drug effects | Cytoprotection | Diterpenes - pharmacology | Myocardial Infarction - metabolism | Potassium Channels - drug effects | Rats, Sprague-Dawley | Myocardial Reperfusion Injury - physiopathology | Myocardial Reperfusion Injury - metabolism | Myocytes, Cardiac - pathology | Animals | Myocytes, Cardiac - drug effects | Myocytes, Cardiac - metabolism | Myocardial Infarction - prevention & control | Protective Agents - administration & dosage | Myocardial Reperfusion Injury - prevention & control | Index Medicus
Journal Article
Heart and Vessels, ISSN 0910-8327, 7/2016, Volume 31, Issue 7, pp. 1154 - 1161
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A14474 - A14474
BackgroundThe risk of major bleeding in patients with atrial fibrillation (AF) is stratified by risk scores such as HAS-BLED, ORBIT and ATRIA score. However,... 
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A13365 - A13365
BackgroundOral anticoagulants (OAC) are effective in preventing stroke in patients with atrial fibrillation (AF), and many AF patients have concomitant... 
Journal Article
Heart and Vessels, ISSN 0910-8327, 12/2016, Volume 31, Issue 12, pp. 2025 - 2034
Journal Article
Heart and Vessels, ISSN 0910-8327, 7/2016, Volume 31, Issue 7, pp. 1084 - 1090
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A13376 - A13376
BackgroundHeart failure (HF) is one of the major problems of atrial fibrillation (AF). HF is categorized by ejection fraction (EF) into preserved EF... 
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A13355 - A13355
IntroductionAtrial fibrillation (AF) increases the risk of thromboembolism, and oral anticoagulants (OAC) are highly effective in preventing it. However, the... 
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A13354 - A13354
BackgroundHeart failure (HF) is an important comorbidity of atrial fibrillation (AF). Pre-existing HF and organic heart disease (HD) such as valvular heart... 
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A13280 - A13280
BackgroundThe risk of clinical events in patients with atrial fibrillation (AF) were commonly stratified by the scheme based on the disease subtype, such as... 
Journal Article
Heart and Vessels, ISSN 0910-8327, 06/2018, Volume 33, Issue 12, pp. 1 - 2
In the original publication of the article, the data of Body mass index ≥ 25 (kg/m ) is published incorrectly in Table 1. Since this is categorical variable,... 
Care and treatment | Cardiology | Atrial fibrillation | Patient outcomes | Cardiac patients | Body mass index | Fibrillation | Body mass | Body size
Journal Article
Journal Article